Amanote Research

Amanote Research

    RegisterSign In

Nanocomposite Treatment Reduces Disease and Lethality in a Murine Model of Acute Graft-Versus-Host Disease and Preserves Anti-Tumor Effects

PLoS ONE - United States
doi 10.1371/journal.pone.0123004
Full Text
Open PDF
Abstract

Available in full text

Categories
Multidisciplinary
Date

April 13, 2015

Authors
Priscila T. T. BernardesBárbara M. RezendeCarolina B. ResendeTalles P. De PaulaAlesandra C. ReisWilliam A. GonçalvesElias G. VieiraMaurício V. B. PinheiroDanielle G. SouzaMarina G. M. CastorMauro M. TeixeiraVanessa Pinho
Publisher

Public Library of Science (PLoS)


Related search

Donor and Host B7-H4 Expression Negatively Regulates Acute Graft-Versus-Host Disease Lethality

JCI insight
Medicine
2019English

Acute Graft Versus Host Disease: A Brief Review

Turkish Journal of Haematology
Hematology
2019English

Sirolimus for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2009English

Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease With Daclizumab and Etanercept

Bone Marrow Transplantation
TransplantationHematology
2005English

Graft-Versus-Host Disease

New England Journal of Medicine
Medicine
1991English

Graft Versus Host Disease

Bone Marrow Transplantation
TransplantationHematology
2000English

Acute Graft-Versus-Host Disease: Inflammation Run Amok?

Journal of Clinical Investigation
Medicine
2001English

Graft Versus Host Disease

2020English

Treatment of Chronic Graft-Versus-Host Disease in 2011

Current Opinion in Hematology
Hematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy